Hollencrest Securities »

Verve Therapeutics shares owned by Hollencrest Securities

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Hollencrest Securities from 13F filings

Historical chart of Hollencrest Securities investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Hollencrest Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Hollencrest Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $739 53 13.94
2023-09-30 $703 53 13.26
2023-06-30 $993 53 18.75
2023-03-31 $764 53 14.42
2022-12-31 $1.0k 53 19.36

More positions owned by Hollencrest Securities

Spdr S&p 500 Etf Trust Etf (SPY)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard S&p 500 Etf Etf (VOO)
United Parcel Service Inc Cl B Stock (UPS)
Technology Select Sector Spdr Fund Etf (XLK)
Salesforce Stock (CRM)
Apple Stock (AAPL)
Simplify Short Term Treasury Futures Strategy Etf Etf (TUA)
Pacer Us Cash Cows 100 Etf Etf (COWZ)
Abrdn Physical Platinum Shares Etf Etf (PPLT)
Microsoft Corp Stock (MSFT)
Tesla Stock (TSLA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Fidelity National Financial In Fnf Group Stock (FNF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)

View all positions for Hollencrest Securities

Top funds holding Verve Therapeutics

Alphabet
ARK Investment Management
Vanguard Group
Federated Investors
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Jpmorgan Chase & Co
Arch Venture Corp
Redmile Group
Baker Bros. Advisors
EcoR1 Capital
BVF
Palo Alto Investors
Citadel Advisors

View all funds holding Verve Therapeutics